{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:40:29Z","timestamp":1789681229017,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jacep.2025.03.020","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T14:34:00Z","timestamp":1747233240000},"page":"1511-1518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Flecainide for the Treatment of Andersen-Tawil Syndrome"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8239-0123","authenticated-orcid":false,"given":"Tomer D.","family":"Mann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayhan","family":"Yoruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel A.","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auke T.","family":"Bergeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn J.","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"van der Werf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Gollob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4828-5768","authenticated-orcid":false,"given":"Habib","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhayan","family":"Sanatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasanth","family":"Vedantham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasiea","family":"Yesaulov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7982-1586","authenticated-orcid":false,"given":"Andrew D.","family":"Krahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1472-0258","authenticated-orcid":false,"given":"Rafik","family":"Tadros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur A.","family":"Wilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Ackerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvin M.","family":"Scheinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jacep.2025.03.020_bib1","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.nmd.2018.03.006","article-title":"Prevalence and mutation spectrum of skeletal muscle channelopathies in the Netherlands","volume":"28","author":"Stunnenberg","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"10.1016\/j.jacep.2025.03.020_bib2","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0092-8674(01)00342-7","article-title":"Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen\u2019s syndrome","volume":"105","author":"Plaster","year":"2001","journal-title":"Cell"},{"issue":"15","key":"10.1016\/j.jacep.2025.03.020_bib3","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.jacc.2020.02.033","article-title":"Natural history and risk stratification in Andersen-Tawil syndrome type 1","volume":"75","author":"Mazzanti","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jacep.2025.03.020_bib4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/europace\/eul188","article-title":"Sudden cardiac death in Andersen-Tawil syndrome","volume":"9","author":"Peters","year":"2007","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.jacep.2025.03.020_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1540-8167.2004.03369.x","article-title":"Suppression of bidirectional ventricular tachycardia and unmasking of prolonged QT interval with verapamil in Andersen\u2019s Syndrome","volume":"15","author":"Kannankeril","year":"2004","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"5","key":"10.1016\/j.jacep.2025.03.020_bib6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1651-2227.1971.tb06990.x","article-title":"Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies: a new syndrome?","volume":"60","author":"Andersen","year":"1971","journal-title":"Acta Paediatr Scand"},{"issue":"3","key":"10.1016\/j.jacep.2025.03.020_bib7","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/ana.410350313","article-title":"Andersen\u2019s syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features","volume":"35","author":"Tawil","year":"1994","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.jacep.2025.03.020_bib8","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1093\/europace\/eut326","article-title":"Andersen-Tawil syndrome, scarier for the doctor than for the patient? Who, when, and how to treat","volume":"15","author":"Wilde","year":"2013","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.jacep.2025.03.020_bib9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1540-8167.2007.00910.x","article-title":"Flecainide suppresses bidirectional ventricular tachycardia and reverses tachycardia-induced cardiomyopathy in Andersen-Tawil syndrome","volume":"19","author":"Pellizz\u00f3n","year":"2008","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"12","key":"10.1016\/j.jacep.2025.03.020_bib10","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/europace\/eut160","article-title":"Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation","volume":"15","author":"Delannoy","year":"2013","journal-title":"Europace"},{"issue":"4","key":"10.1016\/j.jacep.2025.03.020_bib11","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.hrthm.2006.12.031","article-title":"Flecainide for recurrent malignant ventricular arrhythmias in two siblings with Andersen-Tawil syndrome","volume":"4","author":"B\u00f6kenkamp","year":"2007","journal-title":"Heart Rhythm"},{"issue":"35","key":"10.1016\/j.jacep.2025.03.020_bib12","doi-asserted-by":"crossref","first-page":"15631","DOI":"10.1073\/pnas.1004021107","article-title":"Flecainide increases Kir2.1 currents by interacting with cysteine 311, decreasing the polyamine-induced rectification","volume":"107","author":"Caballero","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.jacep.2025.03.020_bib13","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1161\/CIRCRESAHA.116.305017","article-title":"Ion channel macromolecular complexes in cardiomyocytes: roles in sudden cardiac death","volume":"116","author":"Abriel","year":"2015","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.jacep.2025.03.020_bib14","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.hrthm.2014.12.009","article-title":"Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with KCNJ2 mutations","volume":"12","author":"Miyamoto","year":"2015","journal-title":"Heart Rhythm"},{"issue":"6","key":"10.1016\/j.jacep.2025.03.020_bib15","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.cjco.2020.05.006","article-title":"The Hearts in Rhythm Organization: a Canadian National Cardiogenetics Network","volume":"2","author":"Davies","year":"2020","journal-title":"CJC Open"},{"issue":"5","key":"10.1016\/j.jacep.2025.03.020_bib16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"20","key":"10.1016\/j.jacep.2025.03.020_bib17","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1161\/CIRCULATIONAHA.111.028258","article-title":"Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of LQTS probands","volume":"124","author":"Sy","year":"2011","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jacep.2025.03.020_bib18","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0735-1097(00)00962-1","article-title":"Measurement, interpretation and clinical potential of QT dispersion","volume":"36","author":"Malik","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.jacep.2025.03.020_bib19","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1161\/CIRCULATIONAHA.104.472498","article-title":"Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype","volume":"111","author":"Zhang","year":"2005","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.jacep.2025.03.020_bib20","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1540-8167.1998.tb00890.x","article-title":"U wave: Facts, hypotheses, misconceptions, and misnomers","volume":"9","author":"Surawicz","year":"1998","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"4","key":"10.1016\/j.jacep.2025.03.020_bib21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/CRD.0000000000000326","article-title":"Andersen-Tawil Syndrome: a comprehensive review","volume":"29","author":"P\u00e9rez-Riera","year":"2021","journal-title":"Cardiol Rev"},{"issue":"2","key":"10.1016\/j.jacep.2025.03.020_bib22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1540-8159.2004.00403.x","article-title":"When U say \u201cU waves,\u201d what do U mean?","volume":"27","author":"Viskin","year":"2004","journal-title":"PACE - Pacing Clin Electrophysiol"},{"issue":"5","key":"10.1016\/j.jacep.2025.03.020_bib23","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/01.CIR.79.5.1000","article-title":"Amplification of flecainide-induced ventricular conduction slowing by exercise. A potentially significant clinical consequence of use-dependent sodium channel blockade","volume":"79","author":"Ranger","year":"1989","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jacep.2025.03.020_bib24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/CIRCRESAHA.120.316819","article-title":"RYR2 channel inhibition is the principal mechanism of flecainide action in CPVT","volume":"128","author":"Kryshtal","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.jacep.2025.03.020_bib25","article-title":"The antiarrhythmic mechanisms of flecainide in catecholaminergic polymorphic ventricular tachycardia","volume":"13","author":"Li","year":"2022","journal-title":"Front Physiol"},{"issue":"10","key":"10.1016\/j.jacep.2025.03.020_bib26","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/s44161-022-00145-2","article-title":"Kir2.1 dysfunction at the sarcolemma and the sarcoplasmic reticulum causes arrhythmias in a mouse model of Andersen\u2013Tawil syndrome type 1","volume":"1","author":"Mac\u00edas","year":"2022","journal-title":"Nat Cardiovasc Res"},{"issue":"2","key":"10.1016\/j.jacep.2025.03.020_bib27","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.bpj.2017.11.3775","article-title":"Sarcoplasmic reticulum Ca2+ release uses a cascading network of intra-SR and channel countercurrents","volume":"114","author":"Zsolnay","year":"2018","journal-title":"Biophys J"},{"issue":"8","key":"10.1016\/j.jacep.2025.03.020_bib28","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1085\/jgp.201812035","article-title":"Tracking the sarcoplasmic reticulum membrane voltage in muscle with a FRET biosensor","volume":"150","author":"Sanchez","year":"2018","journal-title":"J Gen Physiol"},{"issue":"8","key":"10.1016\/j.jacep.2025.03.020_bib29","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1085\/jgp.201812084","article-title":"No voltage change at skeletal muscle SR membrane during Ca2+ release-just Mermaids on acid","volume":"150","author":"Melzer","year":"2018","journal-title":"J Gen Physiol"},{"issue":"11","key":"10.1016\/j.jacep.2025.03.020_bib30","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.hrthm.2009.06.033","article-title":"Catecholaminergic polymorphic ventricular tachycardia: a paradigm to understand mechanisms of arrhythmias associated to impaired Ca2+ regulation","volume":"6","author":"Cerrone","year":"2009","journal-title":"Heart Rhythm"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X2500180X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X2500180X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:12:57Z","timestamp":1782958377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X2500180X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2405500X2500180X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2025.03.020","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Flecainide for the Treatment of Andersen-Tawil Syndrome","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2025.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}